List of posters

A detailed overview of all events can be found in the congress planner.

Filter
Code
Title
P01
Update on functional drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
Poster 1. New developments in 3D cell culture for functional precision medicine
H. Peterziel Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergL. Becker Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergA. Loboda Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergA. Schmidt Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergS. Herter Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergX. Gerloff Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergR. Autry Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergT. Holland-Letz German Cancer Research Center (DKFZ)A. Kopp-Schneider German Cancer Research Center (DKFZ)O. Witt Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergI. Oehme Presenter Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) Heidelberg
P02
PhoxyCube and MicrosCube - New monitoring methods and systems for 2D and 3D cell culture
Poster 2. 3D models for drug development/discovery
G. Liebsch Presenter PreSens Precision Sensing GmbHR. Meier PreSens Precision Sensing GmbH
P03
Potential of 3D skin models in genetic research of ARCI
Poster 3. Clinical applications and regenerative medicine
H. Hsu-Rehder Medical Center - University of FreiburgC. Glocker Medical Center - University of FreiburgC. Aldrian Medical Center - University of FreiburgE. Dikici Presenter Medical Center - University of FreiburgJ. Fischer Medical Center - University of Freiburg
P04
Improving insights into 3D Cell Cultures: AI-assisted localization of cells in hydrogel cultures through brightfield Z-Stack-Microscopy
Poster 6. Analysis in 3D
N. Ulber Presenter Leibniz Universität HannoverT. Fleischhammer Leibniz Universität HannoverP. Keselman Sartorius AGJ. Austerjost Sartorius AGI. Pepelanova Leibniz Universität HannoverP. Lindner Leibniz Universität HannoverA. Lavrentieva Leibniz Universität Hannover
P05
Histone deacetytlase inhibitors are a valuable addition to therapy regimes in primary and metastatic colorectal cancer.
Poster 2. 3D models for drug development/discovery
S. Schmitz LMU University Hospital, LMU MunichR. Ulbrich LMU University Hospital, LMU MunichJ. Werner LMU University Hospital, LMU MunichB. Mayer Presenter LMU University Hospital, LMU Munich
P06
Optical oxygen measurements using confocal instruments
Poster 6. Analysis in 3D
M. Klesen Karlsruhe Institute of Technology (KIT)C. Nies Karlsruhe Institute of Technology (KIT)C. Grün Presenter Karlsruhe Institute of Technology (KIT)E. Gottwald Karlsruhe Institute of Technology (KIT)
P07
Modeling and targeting the tumor microenvironment in therapy resistant neuroblastomas
Poster 2. 3D models for drug development/discovery
M. Emperador Melero Presenter Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergL. RÖSCH Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergS. HERTER Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergO. ERMAKOVA Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergL. RANGEL School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology SydneyJ. BRAND Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales SydneyJ. MURRAY Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales SydneyM. HARBER Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales SydneyE. DOLMAN Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales SydneyF. VALDES-MORA Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales SydneyD. GALLEGO-ORTEGA School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology SydneyH. PETERZIEL Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergO. WITT Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergI. OEHME Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) Heidelberg
P08
Multi-parametric drug screening identifies specific vulnerabilities of mesenchymal neuroblastomas
Poster 5. Automation and further enabling technologies
S. Herter Presenter Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergM. Emperador Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergK. Smyrilli Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergD. Kocher Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergS. Celikyürekli Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergC. Zeiser Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergS. Kreth Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergK. Henrich Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergK. Maass Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergJ. Rettenmeier Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergH. Peterziel Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergF. Westermann Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergA. Hamacher Brady Johns Hopkins University BaltimoreO. Witt Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergI. Oehme Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) Heidelberg
P09
Sensor arrays for oxygen measurement in 3D cultures – effect of cisplatin and acetaminophen
Poster 6. Analysis in 3D
E. Gottwald Presenter Karlsruhe Institute of Technology (KIT)E. Schwarz Karlsruhe Institute of Technology (KIT)C. Nies Karlsruhe Institute of Technology (KIT)G. Liebsch PreSens Precision Sensing GmbHC. Grün Karlsruhe Institute of Technology (KIT)
P10
In-vitro models to study antiviral mechanism of influenza defective interfering particles
Poster 2. 3D models for drug development/discovery
P. Opitz Presenter Otto-von-Guericke University MagdeburgD. Rüdiger Max Planck Institute for Dynamics of Complex Technical SystemsN. Wynserski Max Planck Institute for Dynamics of Complex Technical SystemsS. Kupke Max Planck Institute for Dynamics of Complex Technical SystemsU. Reichl Max Planck Institute for Dynamics of Complex Technical Systems
P11
Development of a scalable and semi-automated bioreactor process for 3D osteogenic differentiation of human MSCs
Poster 5. Automation and further enabling technologies
J. Dreger Presenter Leibniz Universität HannoverD. Contreras Leibniz Universität HannoverL. Budde Leibniz Universität HannoverT. Seel Leibniz Universität HannoverD. Egger Leibniz Universität Hannover
P12
Human brown and beige adipocyte 3D Cell Culture models for enhanced functional insights
Poster 2. 3D models for drug development/discovery
A. Wagner Presenter Technical University of MunichT. Dinh Technical University of MunichF. Acosta Turku University Hospital, FinlandJ. Örling Turku University Hospital, FinlandM. Wabitsch University Medical Center UlmK. Virtanen Turku University Hospital, FinlandM. Klingenspor Technical University of Munich
P13
A lentiviral reporter platform for live imaging screening of 3D human lung organoids
Poster 2. 3D models for drug development/discovery
M. Guedes Presenter University of SaarlandM. Brand University of SaarlandC. Beisswenger University of SaarlandD. Yildiz University of Saarland
P14
3D spheroid model for trilineage differentiation of mesenchymal stem/stromal cells under physiological conditions
Poster 2. 3D models for drug development/discovery
J. Moldaschl Presenter BOKU UniversityS. Toegel Medical University of ViennaM. Keck Agaplesion Diakonieklinikum HamburgU. Hiden Medical University of GrazD. Egger Gottfried Wilhelm Leibniz University HannoverC. Kasper BOKU University
P15
A systematic cell culture array for efficient generation of human long-term 3D sarcoma models
Poster 1. New developments in 3D cell culture for functional precision medicine
C. Dagostino Presenter National Center for Tumor Diseases Dresden (NCT/UCC) and DKFZW. Hussain National Center for Tumor Diseases Dresden (NCT/UCC) and DKFZJ. Paluncic National Center for Tumor Diseases Dresden (NCT/UCC) and DKFZM. Zoccoler Technical University of Dresden, GermanyJ. Pablik University Hospital Carl Gustav CarusD. Richter National Center for Tumor Diseases Dresden (NCT/UCC) and DKFZA. Klimova Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität DresdenA. Banito Hopp Children's Cancer Center, Heidelberg (KiTZ)J. Wagner German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)I. Mateska National Center for Tumor Diseases Dresden (NCT/UCC) and DKFZS. Schulze University Hospital Carl Gustav Carus, TUDD. Stange University Hospital Carl Gustav CarusI. Oehme Hopp Children’s Cancer Center Heidelberg (KiTZ)S. Richter National Center for Tumor Diseases Dresden (NCT/UCC), Sarcoma Center, University Hospital Carl Gustav Carus Dresden, Dresden University of TechnologyS. Pfister Hopp Children's Cancer Center Heidelberg (KiTZ)S. Fröhling National Center for Tumor Diseases (NCT)C. Scholl German Cancer Research Center (DKFZ)J. Weitz University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität DresdenK. Schaser University Hospital Carl Gustav Carus, TUDC. Heining National Center for Tumor Diseases Dresden (NCT/UCC) Dresden, DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, DKTKH. Glimm National Center for Tumor Diseases Dresden (NCT/UCC) Dresden, DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, DKTKC. Ball National Center for Tumor Diseases Dresden (NCT/UCC) Dresden, DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, DKTK
P16
Identification of novel combinatorial treatment options for childhood brain cancers
Poster 3. Clinical applications and regenerative medicine
S. Laternser Presenter University Childrens Hospital of ZurichB. Kritzer University Childrens Hospital of ZurichM. Freitas PreComb Therapeutics AGS. Manser PreComb Therapeutics AGJ. Kelm PreComb Therapeutics AGJ. Nazarian University Childrens Hospital of Zurich
P17
Identification of novel therapeutic options for the treatment of recurrent glioblastoma
Poster 3. Clinical applications and regenerative medicine
M. Bouzereau University Hospital ZurichM. Freitas PreComb Therapeutics AGS. Manser PreComb Therapeutics AGJ. Kelm Presenter PreComb Therapeutics AGT. Weiss University Hospital Zurich
P18
Animal-free workflow for the fabrication, propagation and automated handling of multicellular tumor spheroids to increase standardization in 3D cell culture
Poster 5. Automation and further enabling technologies
S. Zimmermann Presenter University FreiburgN. Noroozi University FreiburgM. Hassanbeiki University FreiburgV. Zieger University FreiburgD. Frejek Hahn-SchickardL. Zausch University FreiburgR. Zengerle Hahn-SchickardS. Kartmann Hahn-Schickard
P19
G-force guided self-assembly of collagen hydrogels for optically accurate cornea analogues
Poster 2. 3D models for drug development/discovery
L. Grumm Presenter University Clinic Düsseldorf, GermanyL. Szepanowski University Clinic Düsseldorf, GermanyJ. Witt University Clinic Düsseldorf, GermanyG. Geerling University Clinic Düsseldorf, GermanyF. Groeber-Becker University Clinic Düsseldorf, Germany
P20
Three-dimensional co-culture model for patient-specific B-cell lymphomas
Poster 2. 3D models for drug development/discovery
T. Fleischhammer Presenter Gottfried Wilhelm Leibniz University HannoverN. Qin University Clinic Düsseldorf, GermanyS. Dietrich University Clinic Düsseldorf, GermanyI. Pepelanova Gottfried Wilhelm Leibniz University HannoverA. Lavrentieva Gottfried Wilhelm Leibniz University Hannover
P21
3D-printed microfluidic platform for in vitro analysis of neurovascular unit responses to ischemic condition
Poster 2. 3D models for drug development/discovery
K. Meyer Presenter Universität Augsburg & Lund UniversityS. Winkler Universität AugsburgX. Kraus Universität AugsburgA. Meissner Universität Augsburg & Lund UniversityJ. Bahnemann Universität Augsburg
P22
Automation of long term dynamic drug testing for clinical implementation of real world precision oncology
Poster 5. Automation and further enabling technologies
O. Mauti PreComb Therapeutics AGD. Felder Eastern Switzerland University of Applied SciencesL. Müller Eastern Switzerland University of Applied SciencesA. Koller Eastern Switzerland University of Applied SciencesM. Herzog University Hospital ZurichS. Kollar University Hospital ZurichC. Pauli University Hospital ZurichP. Steiner PreComb Therapeutics AGJ. Kelm Presenter PreComb Therapeutics AG
P23
Shortening of incubation times for the dissociation of 3D cell cultures
Poster 5. Automation and further enabling technologies
S. Hartmann-Fattler Presenter Fraunhofer Institute for Manufacturing Engineering and Automation IPAF. Mayerle Fraunhofer Institute for Manufacturing Engineering and Automation IPAS. Knoth Fraunhofer Institute for Manufacturing Engineering and Automation IPAP. Lebhardt Fraunhofer Institute for Manufacturing Engineering and Automation IPA
P24
Application of 3D- isolation and cultivation of Mesenchymal Stem Cells (MSC) using GelMA Hydrogel
Poster 5. Automation and further enabling technologies
N. Hussein Presenter Leibniz University HannoverY. Roger Hannover Medical SchoolI. Pepelanova Leibniz University HannoverA. Lavrentieva Leibniz University HannoverA. Hoffmann Hannover Medical SchoolD. Egger Leibniz University Hannover
P25
A practical guide to tumour spheroids in cancer nanomedicine research
Poster 2. 3D models for drug development/discovery
A. Evtushenko Presenter University of CambridgeC. Yadav University of CambridgeB. Lozano-Torres University of CambridgeA. Bistrovic Popov University of CambridgeL. Dvinskikh University of CambridgeC. Kaminski University of CambridgeL. Fruk University of Cambridge
P26
Development of a sensor-integrated Vessel-on-a-Chip platform to study Sphingosine-1-phosphate's role in endothelial dysfunction
Poster 2. 3D models for drug development/discovery
X. Kraus Presenter University AugsburgD. Wörle University AugsburgS. Winkler University AugsburgK. Meyer University AugsburgC. Westerhausen University AugsburgA. Meissner University AugsburgJ. Bahnemann University Augsburg
P27
Microfluidic-driven culture and automated analysis of colon cancer spheroids using light sheet microscopy
Poster 6. Analysis in 3D
A. Hermann Presenter Institute for Bioprocessing and Analytical Measurement Techniques e.V.F. Moll Institute for Bioprocessing and Analytical Measurement Techniques e.V.R. Römer Institute for Bioprocessing and Analytical Measurement Techniques e.V.S. Wiedermeier Institute for Bioprocessing and Analytical Measurement Techniques e.V.K. Lemke Institute for Bioprocessing and Analytical Measurement Techniques e.V.
P28
User-friendly droplet-based high-throughput cell viability assay for drug screening in tumor spheroids
Poster 2. 3D models for drug development/discovery
M. Saupe Institute for Bioprocessing and Analytical Measurement Techniques e.V.S. Wiedemeier Institute for Bioprocessing and Analytical Measurement Techniques e.V.F. Moll Institute for Bioprocessing and Analytical Measurement Techniques e.V.R. Römer Institute for Bioprocessing and Analytical Measurement Techniques e.V.K. Lemke Presenter Institute for Bioprocessing and Analytical Measurement Techniques e.V.
P29
Novel genetically encoded FRET-based Biosensors for tracking apoptosis in 3D cancer models
Poster 1. New developments in 3D cell culture for functional precision medicine
M. Kirsten Presenter Leibniz Universität HannoverC. Ude PreSens Precision Sensing GmbHG. John PreSens Precision Sensing GmbHA. Lavrentieva Leibniz Universität Hannover
P30
Impact of donor variability on microgel-encapsulated mesenchymal stem cells in small scale bioreactors
Poster 1. New developments in 3D cell culture for functional precision medicine
C. Kasper Presenter BOKU UniversityO. Garcia-Aponte BOKU UniversityM. Serra BOKU UniversityS. Kahlenberg BOKU UniversityD. Egger Leibniz University Hannover
P31
P32
SmartMembrane: a cell culture platform for in vitro drug testing with non-invasive online cell measurements and AI-based classification
Poster 4. AI and data sciences
B. Tang TU BraunschweigV. Krajka Presenter TU BraunschweigM. Liu German Research Center for Artificial IntelligenceW. Zhao TU BraunschweigS. Reichl TU BraunschweigA. Dietzel TU Braunschweig
P33
Real-time monitoring of tissue vitality and inflammatory reactions in full-thickness skin models in a microfluidic environment
Poster 2. 3D models for drug development/discovery
M. Flechner Presenter Fraunhofer IZI-BBH. Glasebach Fraunhofer IGBV. Mielke Fraunhofer IZI-BBA. Burger-Kentischer Fraunhofer IGBK. Uhlig Fraunhofer IZI-BB
P34
Systematic generation and characterization of a living biobank of pan-cancer wide patient-derived tumor 3D organoids as a platform for basic, translational and clinical research
Poster 1. New developments in 3D cell culture for functional precision medicine
I. Mateska Presenter National Center for Tumor Diseases Dresden (NCT/UCC), Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität DresdenD. Stange University Hospital Carl Gustav Carus DresdenC. Ball National Center for Tumor Diseases Dresden (NCT/UCC) Dresden, DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, DKTK
P35
A self-renewing, human-relevant in vitro model for inflammatory gastrointestinal disease modeling
Poster 2. 3D models for drug development/discovery
A. Spreen Altis BiosystemsL. Boone Altis BiosystemsC. Pike Presenter Altis BiosystemsM. Bunger Altis BiosystemsL. Boazak Altis Biosystems
P36
Unveiling the dynamics of scratch assays: continuous, label-free monitoring of cell migration using lensfree imaging and AI
Poster 5. Automation and further enabling technologies
A. Jötten Presenter Ludwig-Maximilians-University MunichP. Paulitschke Ludwig-Maximilians-University Munich, PHIO scientific GmbH
P37
Advancing cell-based assay reproducibility through lensfree imaging and AI integration
Poster 4. AI and data sciences
P. Paulitschke Presenter Ludwig-Maximilians-University Munich, PHIO scientific GmbHA. Jötten Ludwig-Maximilians-University Munich
P38
Roboscreen: a multiplexed diagnostic platform for comprehensive drug response evaluation in the patient-derived spheroid model
Poster 5. Automation and further enabling technologies
P. Mela Presenter TUMS. Schmitz LMUM. Niederreiter LMUV. Schaffrin Opto GmbHM. Flachmann Opto GmbHM. Gutbrod Presens Precision Sensing GmbHB. Mayer LMU
P39
Advancements in 3D cell culture within hydrogel microparticles using Dolomite Microfluidics
Poster 1. New developments in 3D cell culture for functional precision medicine
M. Wu Presenter Dolomite Microfluidics (Unchained Labs)
P40
A modular dynamic culture system with optimized inserts for organotypic tissue culture
Poster 2. 3D models for drug development/discovery
F. Moll Presenter Institute for Bioprocessing and Analytical Measurement Techniques e.V.S. Wiedemeier Institute for Bioprocessing and Analytical Measurement Techniques e.V.P. Brunotte TPK-Kunststofftechnik GmbHK. Lemke Institute for Bioprocessing and Analytical Measurement Techniques e.V.
P41
A standardized 3D model for oncology research
Poster 1. New developments in 3D cell culture for functional precision medicine
C. Yadav Presenter University of CambridgeA. Evtushenko University of CambridgeA. Popov University of CambridgeB. Torres University of CambridgeA. Baker University of CambridgeL. Fruk University of Cambridge
P42
Optimizing brain cancer drug discovery with aNSC-derived 3D models for precision medicine and high-throughput screening
Poster 2. 3D models for drug development/discovery
A. Wolfram Presenter Tübingen University HospitalV. Arnold Tübingen University HospitalA. Moskalchuk Tübingen University HospitalC. Romero-Nieto University of Castilla-La ManchaL. Sevenich Tübingen University Hospital
P43
Development of 3D brain cancer models using aNSCs for improved preclinical accuracy
Poster 2. 3D models for drug development/discovery
V. Arnold Presenter University of TübingenA. Wolfram University of TübingenA. Moskalchuk University of TübingenL. Sevenich University of Tübingen
P44
Enable better research with R.E.A.L skin: Realistic, Ethical, Automated and Layered
Poster 1. New developments in 3D cell culture for functional precision medicine
A. Reigl Presenter Fraunhofer Project-Group TigerShark Science K. Tiltmann Fraunhofer Project-Group TigerShark Science N. Köder Fraunhofer Project-Group TigerShark Science A. Hauser Fraunhofer Project-Group TigerShark Science L. Königer Fraunhofer Project-Group TigerShark Science S. Zöphel University Hospital Würzburg P. Klose Julius-Maximilians UniversityL. Kiesewetter Fraunhofer Institut für Silicatforschung ISCM. Ackermann REBIRTH Research Center for translational and regenerative medicineM. Schinke Fraunhofer Institute for Toxicology and Experimental Medicine ITEMN. Lachmann Fraunhofer Institute for Toxicology and Experimental Medicine ITEMA. Weghofer Eberhard-Karls-UniversityP. Loskill NMI Natural and Medical Sciences Institute at the University of TübingenF. Groeber-Becker Fraunhofer Institut für Silicatforschung ISCD. Groneberg Fraunhofer Institut für Silicatforschung ISC
P45
Exploring cellular interactions in inflammatory bowel disease using an immunocompetent 3D hydrogel model
Poster 2. 3D models for drug development/discovery
M. García-Díaz Presenter Institute for Bioengineering of CataloniaA. Vila Institute for Bioengineering of CataloniaN. Torras Institute for Bioengineering of CataloniaD. Bartolomé Institute for Bioengineering of CataloniaE. Martínez Institute for Bioengineering of Catalonia
P46
Characterization of hydrogel-based and scaffold-free 3D in vitro constructs using genetically encoded biosensors for hypoxia and reactive oxygen species detection
Poster 1. New developments in 3D cell culture for functional precision medicine
M. Rodríguez Harzi Presenter Leibniz University Hannover
P47
High-yield, improved viability and long-term cultivation of 3D cell models and their gentle sorting according to size
Poster 2. 3D models for drug development/discovery
M. Uhrig Presenter OLS OMNI Life Science
P48
Semi-automated multiplex readout of chemotherapeutic treatments using primary patient-derived cancer organoids & spheroids
Poster 1. New developments in 3D cell culture for functional precision medicine
D. Holthaus Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielA. Quevedo-Olmos Laboratory of Infection Oncology, Institute of Clinical Molecular Biology, CAU & UKSHJ. Schiepanski Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielJ. Dittrich Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielC. Rogmans Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielJ. Weimer Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielM. van Mackelenbergh Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielN. Maass Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielD. Bauerschlag Clinic and Polyclinic for Gynaecology and Reproductive Medicine, University Hospital JenaN. Hedemann Presenter Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel
P49
Functional immuno- and chemotherapeutic testing of cervical cancer organoids
Poster 1. New developments in 3D cell culture for functional precision medicine
D. Holthaus Presenter University Hospital Schleswig-Holstein, Campus KielC. Rogmans University Hospital Schleswig-Holstein, Campus KielI. Gursinski University Hospital Schleswig-Holstein, Campus KielA. Quevedo-Olmos Institute of Clinical Molecular BiologyC. Peters University Hospital Schleswig-Holstein, Campus KielM. Ehsani Institute of Clinical Molecular BiologyJ. Weimer University Hospital Schleswig-Holstein, Campus KielN. Maass University Hospital Schleswig-Holstein, Campus KielM. van Mackelenbergh University Hospital Schleswig-Holstein, Campus KielD. Bauerschlag University Hospital Schleswig-Holstein, Campus KielD. Kabelitz University Hospital Schleswig-Holstein, Campus KielT. Meyer Institute of Clinical Molecular BiologyN. Hedemann University Hospital Schleswig-Holstein, Campus Kiel
P50
Fabrication of 3D biofabricated microfiber constructs for large-scale artificial skeletal muscle tissue engineering
Poster 3. Clinical applications and regenerative medicine
E. Knappe Presenter FILK Freiberg Institute gGmbH
P51
Using a bioluminescence resonance energy transfer biosensor to investigate FFA4 receptor function in 3D cultured adipocytes
Poster 2. 3D models for drug development/discovery
L. Vita Presenter University of GlasgowB. Dibnah University of GlasgowE. Russell Bioascent Drug Discovery LtdB. Hudson University of Glasgow
P52
Automated cell perfusion for 3D cell culture and tissue engineering
Poster 5. Automation and further enabling technologies
C. Ivanova Presenter Microfluidics Innovation CenterO. Fournier Microfluidics Innovation CenterT. Gavoille Microfluidics Innovation CenterA. Morin Microfluidics Innovation CenterC. Betterelli Giuliano Microfluidics Innovation CenterE. Bancel Microfluidics Innovation CenterA. Geffrault Microfluidics Innovation CenterJ. Sepulveda Microfluidics Innovation Center
P53
Towards serum-free collagen production: extraction and characterization of human collagen from 3D cell sheets
Poster 2. 3D models for drug development/discovery
I. Prade Presenter FILK Freiberg Institute gGmbHC. Seidel FILK Freiberg Institute gGmbHB. Voigt FILK Freiberg Institute gGmbHM. Meyer FILK Freiberg Institute gGmbH
P54
Modeling immunotherapies in live 3D human cancer tissue perfusion bioreactors
Poster 1. New developments in 3D cell culture for functional precision medicine
Y. Zhang Presenter University Hospital and Comprehensive Cancer Center TübingenP. Bucher University TübingenJ. Leibold University TübingenJ. Feucht University TübingenL. Flatz University Hospital TübingenC. Schürch University Hospital and Comprehensive Cancer Center Tübingen
P55
An innovative bioartificial graft system
Poster 3. Clinical applications and regenerative medicine
C. Blume Presenter Leibniz University HannoverS. Loewner Gottfried Wilhelm Leibniz University HannoverJ. Krueger Gottfried Wilhelm Leibniz University HannoverS. Heene Gottfried Wilhelm Leibniz University Hannover
P56
Revealing decitabine sensitization in IDH-WT GBM cells through high-throughput screening of CNS-penetrating drugs using a miniaturized single-spheroid array
Poster 1. New developments in 3D cell culture for functional precision medicine
A. Popova Presenter Karlsruhe Institute of Technology (KIT)M. Salarian Karlsruhe Institute of TechnologyS. Turcan National Center for Tumor Diseases (NCT)P. Levkin Karlsruhe Institute of Technology
P57
High-throughput BBB spheroid arrays to investigate efficacy of therapeutic bispecific antibodies against glioblastoma
Poster 2. 3D models for drug development/discovery
A. Gavrilov Presenter F. Hoffmann-La RocheC. Simonneau F. Hoffmann-La RocheE. Kassianidou F. Hoffmann-La RocheM. Duschmalé F. Hoffmann-La RocheE. Husar F. Hoffmann-La RocheA. Walz F. Hoffmann-La RocheI. Waldhauer F. Hoffmann-La RocheR. Villaseñor F. Hoffmann-La Roche
P58
Non-invasive quality control of tissue-engineered constructs using optical coherence tomography
Poster 6. Analysis in 3D
F. Walz Presenter University Hospital WürzburgJ. Schwebler University Hospital WürzburgO. Pullig University Hospital WürzburgC. Lotz Fraunhofer ISC
P59
“Cancer in MIVO®”: a 3D fluid-dynamic model for recapitulating the tumor microenvironment
Poster 1. New developments in 3D cell culture for functional precision medicine
R. Dhekane Presenter University of milano-bicoccaE. Palama React4lifeS. Scaglione React4life
P60
Use of biopsy-derived tumor organoid for personalized drug testing in recurrent glioblastoma
Poster 2. 3D models for drug development/discovery
A. Wöllner Presenter University Hospital HeidelbergR. Warta University Hospital HeidelbergJ. Cao University Hospital HeidelbergM. Arquilla University Hospital HeidelbergA. Paul University Hospital HeidelbergG. Jungwirth University Hospital HeidelbergW. Wick University Hospital HeidelbergA. von Deimling University Hospital HeidelbergS. Krieg University Hospital HeidelbergA. Unterberg University Hospital HeidelbergM. Jakobs University Hospital HeidelbergC. Herold-Mende University Hospital Heidelberg
P61
From 2D to 4D: a research journey with the CQ1 microscope
Poster 5. Automation and further enabling technologies
M. Schell Presenter Cenibra GmbH
P62
Label-free, real-time live cell assays for 3D Organoids embedded in Matrigel
Poster 2. 3D models for drug development/discovery
M. Benkisser-Petersen Presenter Sartorius Labinstruments GmbH & Co.KG
P63
Time resolved mapping of oxygen consumption and extracellular acidification in 3D tissue models
Poster 6. Analysis in 3D
T. Naber Presenter Fraunhofer Institute for Electronic Microsystems and Solid State Technologies EMFTL. Frank University of RegensburgC. Danner University of RegensburgL. Pütz University of RegensburgK. Krieg Fraunhofer Institute for Translational Medicine and Pharmacology ITMPO. Pless Fraunhofer Institute for Translational Medicine and Pharmacology ITMPJ. Wegener University of Regensburg
P64
A sensor arrays for simultaneous measurements oxygen, glucose and cellular adhesion in cell culture.
Poster 6. Analysis in 3D
E. Jarosińska Presenter Institute of Physical Chemistry PAS
P65
AI-assisted organoid detection and segmentation across modalities
Poster 4. AI and data sciences
L. Gleiter Presenter Helmholtz MunichM. Hoermann Helmholtz MunichH. Zhang Technical University of MunichN. Ma Freie Universität BerlinP. Paulitschke Ludwig-Maximilians-University MunichT. Peng Helmholtz Munich
P66
Development of an autologous T cell co-culture model to mimic skin involvement in Graft-Versus-Host Disease (GVHD)
Poster 2. 3D models for drug development/discovery
J. Fröhlich Presenter University of BaselE. Parente University of BaselT. Dittmar University of BaselE. Contassot University of BaselA. Navarini University of Basel
P67
Modeling neutrophil-driven skin inflammation with 3D epidermal organoids
Poster 2. 3D models for drug development/discovery
E. Parente Presenter University of Basel